Reference Values for the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) from General Population Samples in the United Kingdom, Italy, and The Netherlands.
Rivermead Post-Concussion Symptoms Questionnaire
patient-reported outcome instruments
post-concussion symptoms
reference values
traumatic brain injury
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
09 Aug 2022
09 Aug 2022
Historique:
received:
20
06
2022
revised:
03
08
2022
accepted:
07
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
After traumatic brain injury (TBI), individuals may experience short- or long-term health burdens, often referred to as post-concussion symptoms (PCS). The Rivermead Post-Concussion Symptoms Questionnaire (RPQ) is one of the commonly used instruments to assess self-reported PCS. To date, no reference values for RPQ have been provided, although they are crucial for clinical practice when evaluating a patient's health status relative to a comparable healthy population. Therefore, the aim of this study is to provide reference values for the United Kingdom, the Netherlands, and Italy. A total of 11,759 individuals (50.3% women) from representative general population samples participated in an online survey (4646 individuals from the UK, 3564 from the Netherlands, and 3549 from Italy). The factorial structure of the RPQ was examined using confirmatory factor analysis (CFA), and results from the general population samples were compared with those from respective TBI samples recruited within the international CENTER-TBI study using multigroup CFA. Reference values were stratified by sex, health status, age, and education using percentiles. The three-factorial model outperformed the one-factorial structure. The general population samples were largely comparable to the corresponding TBI samples, except for items such as dizziness, vision, and sensory sensitivity, which can be considered more TBI-specific. Because of the significant differences between the general population samples, we provided reference values for the total score and for the somatic, emotional, and cognitive scales for each country separately. The reference values provided can now be used in clinical practice and research. Future studies should obtain stratified reference values for other countries and languages to improve accuracy in the diagnosis and treatment of symptom burden after TBI.
Identifiants
pubmed: 36012895
pii: jcm11164658
doi: 10.3390/jcm11164658
pmc: PMC9410233
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : European Union 7th Framework programme
ID : 602150
Organisme : Hannelore Kohl Stiftung
Organisme : OneMind
Organisme : Integra LifeSciences Corporation
Références
Clin Rehabil. 2005 Dec;19(8):878-87
pubmed: 16323387
Neurosurgery. 2015 Jan;76(1):67-80
pubmed: 25525693
Psychol Bull. 1990 Mar;107(2):238-46
pubmed: 2320703
J Consult Clin Psychol. 1987 Aug;55(4):584-594
pubmed: 3624616
J Neurol. 1995 Sep;242(9):587-92
pubmed: 8551320
J Clin Med. 2020 Jul 03;9(7):
pubmed: 32635328
Assessment. 2021 Sep;28(6):1656-1670
pubmed: 32326739
J Clin Med. 2020 Jun 19;9(6):
pubmed: 32575667
Arch Phys Med Rehabil. 2010 Nov;91(11):1650-1660.e17
pubmed: 21044708
Arch Clin Neuropsychol. 2006 May;21(4):339-47
pubmed: 16765018
Behav Res Methods. 2019 Feb;51(1):409-428
pubmed: 29869222
Arch Clin Neuropsychol. 2011 Aug;26(5):461-5
pubmed: 21642664
J Clin Med. 2021 May 28;10(11):
pubmed: 34071667
Brain Inj. 2009 Jun;23(6):489-97
pubmed: 19484622
Brain Inj. 2003 Mar;17(3):199-206
pubmed: 12623496
J Neuropsychiatry Clin Neurosci. 2009 Spring;21(2):181-8
pubmed: 19622689
J Neurol. 2006 Dec;253(12):1603-14
pubmed: 17063314
Lancet Neurol. 2019 Oct;18(10):923-934
pubmed: 31526754
Front Neurol. 2018 Dec 19;9:1113
pubmed: 30619066
J Rehabil Med. 2011 Nov;43(11):997-1002
pubmed: 22031345
Psychometrika. 2016 Dec;81(4):1014-1045
pubmed: 27402166
J Head Trauma Rehabil. 2017 Jan/Feb;32(1):E33-E41
pubmed: 27022956
Appl Neuropsychol. 2003;10(3):137-44
pubmed: 12890639
Front Psychol. 2016 Jun 23;7:912
pubmed: 27445888
Lancet. 1974 Jul 13;2(7872):81-4
pubmed: 4136544
Arch Phys Med Rehabil. 2010 Nov;91(11):1637-40
pubmed: 21044706
J Clin Med. 2022 Jul 14;11(14):
pubmed: 35887853
Am J Emerg Med. 2009 Feb;27(2):182-90
pubmed: 19371526
Brain Inj. 2018;32(5):583-592
pubmed: 29388838
Brain Inj. 2019;33(8):1078-1086
pubmed: 31032649
J Clin Med. 2021 Jun 28;10(13):
pubmed: 34203325
Lancet Neurol. 2017 Dec;16(12):987-1048
pubmed: 29122524
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Clin Rehabil. 2001 Jun;15(3):266-73
pubmed: 11386396
JAMA Neurol. 2019 Sep 01;76(9):1049-1059
pubmed: 31157856
Appl Neuropsychol. 2010 Jan;17(1):1-7
pubmed: 20146116
Brain Inj. 2012;26(1):14-26
pubmed: 22107176
J Clin Med. 2021 Feb 17;10(4):
pubmed: 33671273